Diabetic complications of nephropathy and accelerated atherosclerosis are associated with vascular remodeling and dysregulated angiogenesis. Matrix metalloproteinases (MMP) modify extracellular matrix during vascular remodeling and are excreted in urine of patients with vascular malformation or tumor angiogenesis. We hypothesized that urinary MMP activities would be sensitive biomarkers for vascular remodeling in diabetic complications. Activities of MMP-2, MMP-9, and its complex with neutrophil gelatinase-associated lipocalin (NGAL/MMP-9) were measured by substrate gel zymography in urine from nondiabetic (ND) and type 1 diabetic (T1D) rodents that were susceptible to both T1D-induced plaque angiogenesis and nephropathy, or nephropathy alone. Additionally, these urine activities were measured in ND and T1D adolescents. Urinary MMP-9, MMP-2, and NGAL/MMP-9 activities were increased and more prevalent in T1D compared with ND controls. Urinary MMP-2 activity was detected in mice with T1D-induced plaque neovascularization. In nephropathy models, urinary NGAL/MMP-9 and MMP-9 activities appeared before onset of albuminuria, whereas MMP-2 was absent or delayed. Finally, urinary MMP activities were increased in adolescents with early stages of T1D. Urinary MMP activities may be sensitive, noninvasive, and clinically useful biomarkers for predicting vascular remodeling in diabetic renal and vascular complications. atherosclerosis; diabetic nephropathy; albuminuria; neutrophil gelatinase-associated lipocalin; NGAL; diabetic microvascular complications; diabetic macrovascular complications VASCULAR COMPLICATIONS ARE a major cause of death and morbidity in people with type 1 and type 2 diabetes (T1D and T2D), and diabetic kidney disease often heralds the rapid progression of atherosclerosis. Controlling hyperglycemia and dyslipidemia are important for diabetes management; however, HbA1c and lipid profiles do not sufficiently stratify risk for renal and vascular complications (1,14). Furthermore, C-reactive protein has reduced prognostic significance in diabetes (19,21). Thus new biomarkers for cardiovascular and renal complications would be clinically useful tools in diabetes care.Matrix metalloproteinases (MMP) are activated during angiogenesis and vascular remodeling that can occur during both physiological processes and pathological diseases (2, 32). The MMP family includes over 20 zinc-and calcium-dependent endopeptidases that collectively degrade all forms of extracellular matrix and basement membrane proteins. MMP are secreted from various cell types as proenzymes, activated after proteolytic cleavage and further regulated by binding to specific tissue inhibitors of metalloproteases (TIMPs) (15). Some MMP are excreted in urine with preserved or latent activities, which renders their detection at high sensitivity (27). Even the large 125-kDa complex of MMP-9 and neutrophil gelatinaseassociated lipocalin (NGAL; also known as lipocalin-2), which protects MMP-9 from autodegradation, can be excreted in urine. MMP-2, MMP-9...